bioMerieux

Activities: Regulatory Analysis

Trending Articles

  1. New study poised to shift how the nutraceutical industry thinks about NAD+ support Researchers have uncovered that the botanical complex BluNADBooster outperformed the category’s benchmark precursor ingredient, nicotinamide riboside — commercially sold as...
  2. Clasado to unveil new female athlete prebiotic research on Bimuno GOS at ISENC 2025 Elite athlete study shows Bimuno GOS delivers significant benefits for immunity, gut health and sleep, offering fresh insights into female sports performance
  3. Natural Remedies explores possible GLP-1 support function of its digestive health ingredient Natural Remedies' patented digestive health ingredient GutGard completed a preclinical investigation in October 2025, with a new human clinical study in January 2026 examining...
  4. 2025 has been a landmark year for prebiotics according to Clasado The company reflects on a successful 2025, during which prebiotic science began to gain momentum in health and nutrition product innovation
  5. Lupin, TPG Capital & EQT in talks to acquire Vitabiotics in £1bn takeover Indian pharmaceutical giant Lupin Pharma is reportedly in early-stage negotiations to acquire UK supplement leader Vitabiotics for around £1 billion to capitalise on booming...

Upcoming event

Vitafoods India

11–13 February 2026 | Exhibition | Mumbai See all

Related Content

Manufacturing

bioMérieux to exhibit at SupplySide West 2021

The company will be located at booth No.6634
Regulatory

bioMérieux assay achieves AOAC approval for nutraceuticals

The real-time PCR solution for pathogen detection detects <>E. coli, Salmonella spp.</i> and </i>Staphylococcus aureus</i> from a single universal enrichment in 24 hours
Subscribe now